Publications



The validity of 18F-GE180 as a TSPO imaging agent
Zanotti Fregonara, P, Veronese, M, Pascual, MB, Rostomily, RC, Turkheimer, F & Masdeu, JC 2019, European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-019-4268-4

Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression
Parada, CA, Osbun, J, Kaur, S, Yakkioui, Y, Shi, M, Pan, C, Busald, T, Karasozen, Y, Gonzalez-Cuyar, LF, Rostomily, RC, Zhang, J & Ferreira, M 2018, Scientific Reports, vol. 8, no. 1, 2098. https://doi.org/10.1038/s41598-018-19308-y


An anatomic transcriptional atlas of human glioblastoma
Puchalski, RB, Shah, N, Miller, J, Dalley, R, Nomura, SR, Yoon, JG, Smith, KA, Lankerovich, M, Bertagnolli, D, Bickley, K, Boe, AF, Brouner, K, Butler, S, Caldejon, S, Chapin, M, Datta, S, Dee, N, Desta, T, Dolbeare, T, Dotson, N, Ebbert, A, Feng, D, Feng, X, Fisher, M, Gee, G, Goldy, J, Gourley, L, Gregor, BW, Gu, G, Hejazinia, N, Hohmann, J, Hothi, P, Howard, R, Joines, K, Kriedberg, A, Kuan, L, Lau, C, Lee, F, Lee, H, Lemon, T, Long, F, Mastan, N, Mott, E, Murthy, C, Ngo, K, Olson, E, Reding, M, Riley, Z, Rosen, D, Sandman, D, Shapovalova, N, Slaughterbeck, CR, Sodt, A, Stockdale, G, Szafer, A, Wakeman, W, Wohnoutka, PE, White, SJ, Marsh, D, Rostomily, RC, Ng, L, Dang, C, Jones, A, Keogh, B, Gittleman, HR, Barnholtz-Sloan, JS, Cimino, PJ, Uppin, MS, Dirk Keene, C, Farrokhi, FR, Lathia, JD, Berens, ME, Iavarone, A, Bernard, A, Lein, E, Phillips, JW, Rostad, SW, Cobbs, C, Hawrylycz, MJ & Foltz, GD 2018, Science, vol. 360, no. 6389, pp. 660-663. https://doi.org/10.1126/science.aaf2666


Evaluating the Therapeutic Relevance of Targeting TWIST1 Through Loss of Function Studies in Human Glioblastoma: AANS Annual Scientific Meeting, New Orleans, Louisiana, April 28-May 2, 2018
Mikheev, A, Mikheeva, SA, Severs, LJ, Funk, CC, Huang, L, Mcfaline-Figueroa, JL, Schwensen, J, Trapnell, C, Price, ND, Wong, ST & Rostomily, RC 2018, .



Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma
Mikheev, AM, Mikheeva, SA, Severs, LJ, Funk, CC, Huang, L, Mcfaline-Figueroa, JL, Schwensen, J, Trapnell, C, Price, ND, Wong, ST & Rostomily, RC 2018, Molecular Oncology. https://doi.org/10.1002/1878-0261.12320

Twist1 mediated regulation of glioma tumorigenicity is dependent on mode of mouse neural progenitor transformation
Mikheev, AM, Mikheeva, SA, Tokita, M, Severs, LJ & Rostomily, RC 2017, Oncotarget, vol. 8, no. 64, pp. 107716-107729. https://doi.org/10.18632/oncotarget.22593

Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy
Pollak, J, Rai, KG, Funk, CC, Arora, S, Lee, E, Zhu, J, Price, ND, Paddison, PJ, Ramirez, J-M & Rostomily, RC 2017, PLoS ONE, vol. 12, no. 3, pp. e0172884. https://doi.org/10.1371/journal.pone.0172884

Fragment Length of Circulating Tumor DNA
Underhill, HR, Kitzman, JO, Hellwig, S, Welker, NC, Daza, R, Baker, DN, Gligorich, KM, Rostomily, RC, Bronner, MP & Shendure, J 2016, PLoS Genetics, vol. 12, no. 7, pp. e1006162. https://doi.org/10.1371/journal.pgen.1006162

Improvement in Visual Fields After Treatment of Intracranial Meningioma With Bevacizumab
Ly, KI, Hamilton, SR, Rostomily, RC, Rockhill, JK & Mrugala, MM 2015, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, vol. 35, no. 4, pp. 382-6. DOI: 10.1097/WNO.0000000000000253

Safety and Efficacy of Preoperative Embolization of Intracranial Hemangioblastomas
Ene, CI, Xu, D, Morton, RP, Emerson, S, Levitt, MR, Barber, J, Rostomily, RC, Ghodke, BV, Hallam, DK, Albuquerque, FC, McDougall, CG, Sekhar, LN, Ferreira, M, Kim, LJ & Chang, SW 2015, Neurosurgery. DOI: 10.1227/NEU.0000000000001014

Outcomes in Reoperated Low-Grade Gliomas
Ramakrishna, R, Hebb, A, Barber, J, Rostomily, R & Silbergeld, D 2015, Neurosurgery, vol. 77, no. 2, pp. 175-184. https://doi.org/10.1227/NEU.0000000000000753

O(6)-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with MGMT promoter methylation in glioblastoma and anaplastic glioma
Bobola, MS, Alnoor, M, Chen, JY-S, Kolstoe, DD, Silbergeld, DL, Rostomily, RC, Blank, A, Chamberlain, MC & Silber, JR 2015, Aging, vol. 3, pp. 1-10. https://doi.org/10.1016/j.bbacli.2014.11.003

Novel targeted therapies in chordoma: An update
Di Maio, S, Yip, S, Al Zhrani, GA, Alotaibi, FE, Al Turki, A, Kong, E & Rostomily, RC 2015, Therapeutics and Clinical Risk Management, vol. 11, pp. 873-883. https://doi.org/10.2147/TCRM.S50526

Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity
Chu, DSH, Bocek, MJ, Shi, J, Ta, A, Ngambenjawong, C, Rostomily, RC & Pun, SH 2015, Journal of Controlled Release, vol. 205, pp. 155-61. https://doi.org/10.1016/j.jconrel.2015.01.013

Periostin is a novel therapeutic target that predicts and regulates glioma malignancy
Mikheev, AM, Mikheeva, SA, Trister, AD, Tokita, MJ, Emerson, SN, Parada, CA, Born, DE, Carnemolla, B, Frankel, S, Kim, DH, Oxford, RG, Kosai, Y, Tozer-Fink, KR, Manning, TC, Silber, JR & Rostomily, RC 2015, Neuro-Oncology, vol. 17, no. 3, pp. 372-382. https://doi.org/10.1093/neuonc/nou161